A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
Clinical trial NCT05347095 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05347095
- Sponsor
- Janssen-Cilag Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-27
- Primary completion
- 2027-03-25
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.